Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 9, 2008Clinical Pharmacology & Therapeutics

Use of ANOVA to Estimate Inter- and Intra-reader Variability for a Group of Readers in Thorough QT/QTc Studies

View Full Paper
Ask AI
Bookmark
Share

Key result

Thorough QT/QTc studies require inter- and intra-reader variability analysis to ensure quality in detecting a mean drug-induced QTc prolongation of >5 ms.

Design

Other

Authors

MNMili NatekarUniversity of FloridaVMVaibhav MahajanCSL (United States)ASAnkita Satra

Discussion

Loading...

Member takes

Implication

Variability analysis is now required for TQT study quality; extends E14 guideline application with ANOVA-based ECG reader assessment.

Structured PICO

I
Intervention
ANOVA to estimate inter- and intra-reader variability
O
Outcome
Estimation of inter- and intra-reader variability in thorough QT/QTc studies

Provides a methodological framework using ANOVA to assess ECG reader variability in thorough QT/QTc studies as required by E14 guidelines.

Cite This Study

Natekar et al. (2008) conducted a review in QT/QTc prolongation. Inter- and intra-reader variability analysis was evaluated. Thorough QT/QTc studies require inter- and intra-reader variability analysis to ensure quality in detecting a mean drug-induced QTc prolongation of >5 ms.

synapsesocial.com/papers/6a1769a01b114e5976b40581https://doi.org/10.1038/sj.clpt.6100481
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Day-to-day reproducibility of Holter beat-by-beat analysis of repolarisation2003 · 4 citations
  2. 2Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval2002 · 442 citations
  3. 3QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.1990 · 1,199 citations
  4. 4Cardiac Repolarization and the Safety of New Drugs Defined by Electrocardiography2006 · 52 citations
  5. 5Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities2005 · 54 citations